Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1576
Vertex
VERX
$2.1B
| $3.45M | 0.01% |
290,500
+21,700
| +8% | +$338K |
2025 Q4
1 quarter
|
|
1577
iShares S&P 100 ETF
OEF
$20.8B
| $3.45M | 0.01% |
10,851
-229
| -2% | -$76.8K |
2025 Q2
3 quarters
|
|
1578
St. Joe Company
JOE
$3.69B
| $3.45M | 0.01% |
54,900
+46,000
| +517% | +$3.08M |
2025 Q4
1 quarter
|
|
1579
STAG Industrial
STAG
$6.94B
| $3.44M | 0.01% |
+95,500
| New | +$3.62M |
2026 Q1
0 quarters
|
|
1580
Freshpet
FRPT
$3.08B
| $3.44M | 0.01% |
58,400
+47,400
| +431% | +$3.33M |
2025 Q3
2 quarters
|
|
1581
Tilly's
TLYS
$136M
| $3.44M | 0.01% |
849,314
+95,102
| +13% | +$192K |
2014 Q4
45 quarters
|
|
1582
Amneal Pharmaceuticals
AMRX
$6.93B
| $3.44M | 0.01% |
276,637
+260,237
| +1,587% | +$3.49M |
2023 Q3
10 quarters
|
|
1583
Ameris Bancorp
ABCB
$5.3B
| $3.44M | 0.01% |
44,069
+24,900
| +130% | +$1.98M |
2025 Q1
4 quarters
|
|
1584
Jefferson Capital
JCAP
$1.14B
| $3.42M | 0.01% |
178,032
+82,432
| +86% | +$1.74M |
2025 Q3
2 quarters
|
|
1585
Provident Financial
PROV
$113M
| $3.42M | 0.01% |
212,353
-6,594
| -3% | -$106K |
2013 Q2
51 quarters
|
|
1586
Comstock Holding Companies
CHCI
$192M
| $3.42M | 0.01% |
180,479
+3,213
| +2% | +$39.8K |
2018 Q2
31 quarters
|
|
1587
North American Construction
NOA
$318M
| $3.42M | 0.01% |
253,500
-7,700
| -3% | -$118K |
2013 Q2
51 quarters
|
|
1588
Clearwater Paper
CLW
$306M
| $3.41M | 0.01% |
237,115
+122,815
| +107% | +$2M |
2025 Q4
1 quarter
|
|
1589
TMC The Metals Company
TMC
$1.48B
| $3.41M | 0.01% |
+730,000
| New | +$4.7M |
2026 Q1
0 quarters
|
|
1590
Movado Group
MOV
$704M
| $3.4M | 0.01% |
139,198
+77,500
| +126% | +$1.83M |
2021 Q3
18 quarters
|
|
1591
Phathom Pharmaceuticals
PHAT
$587M
| $3.4M | 0.01% |
+305,800
| New | +$3.86M |
2026 Q1
0 quarters
|
|
1592
Intellicheck
IDN
$46.2M
| $3.4M | 0.01% |
485,835
+49,470
| +11% | +$269K |
2022 Q1
16 quarters
|
|
1593
PC Connection
CNXN
$2.34B
| $3.39M | 0.01% |
58,000
+100
| +0.2% | +$5.98K |
2022 Q2
15 quarters
|
|
1594
Kforce
KFRC
$918M
| $3.38M | 0.01% |
115,649
+27,205
| +31% | +$827K |
2024 Q1
8 quarters
|
|
1595
Kewaunee Scientific
KEQU
$97.8M
| $3.38M | 0.01% |
98,511
-3,400
| -3% | -$131K |
2013 Q4
49 quarters
|
|
1596
Inhibrx
INBX
$1.4B
| $3.37M | 0.01% |
50,183
-2,417
| -5% | -$179K |
2025 Q3
2 quarters
|
|
1597
National Health Investors
NHI
$3.18B
| $3.37M | 0.01% |
+41,699
| New | +$3.47M |
2026 Q1
0 quarters
|
|
1598
Lakeland Financial Corp
LKFN
$1.41B
| $3.36M | 0.01% |
58,544
-71,685
| -55% | -$4.2M |
2025 Q1
4 quarters
|
|
1599
Lineage Cell Therapeutics
LCTX
$251M
| $3.36M | 0.01% |
2,125,100
-279,700
| -12% | -$472K |
2023 Q2
11 quarters
|
|
1600
AMREP Corp
AXR
$110M
| $3.35M | 0.01% |
119,200
-5,258
| -4% | -$125K |
2014 Q2
47 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.